Next 10 |
SALT LAKE CITY, UT / ACCESSWIRE / March 23, 2021 / Stella Diagnostics, Inc . (OTC Markets:JMDP) ("Stella" or "The Company") announced today that the Company's Chief Executive Officer, Dr. Joe Abdo, will participate in the Benzinga Biotech Small Cap Conference to be held virtually March 24-2...
KANSAS CITY, KS / ACCESSWIRE / March 16, 2021 / Stella Diagnostics, Inc . (OTC PINK:JMDP) ("Stella" or "The Company") has announced a Collaborative Research Agreement with the University of Kansas Medical Center ("KU Medical Center") to assess the predictability and clinical utility of th...
SALT LAKE CITY, UT / ACCESSWIRE / February 25, 2021 / Stella Diagnostics, Inc . (OTC PINK:JMDP) ("Stella" or "The Company") today announced that it has appointed Peter A. Cohen, Seth Platt, and David Seaburg to its Board of Directors. The three new members have decades of experience in asse...
SALT LAKE CITY, UT / ACCESSWIRE / February 17, 2021 / Stella Diagnostics, Inc . (OTC PINK:JMDP) ("Stella" or "The Company") announced today that they have entered into a Collaborative Research Agreement with the Mayo Clinic to assess the predictability and clinical utility of the Company's ...
PALO ALTO, CA / ACCESSWIRE / February 4, 2021 / Stella Diagnostics, Inc . (OTC PINK:JMDP) ("Stella" or "The Company") announced today that they have entered into a partnership with mProbe, Inc., a leading biotechnology company based in California. The aims of the partnership were to build,...
SALT LAKE CITY, UT / ACCESSWIRE / January 7, 2021 / Stella Diagnostics, Inc. (OTC PINK:JMDP), a molecular diagnostics-based organization focused on improving patient management strategies for people living with preneoplastic and cancerous esophageal diseases, today announced that the Company...
NEW YORK, NY / ACCESSWIRE / November 5, 2020 / Stella Diagnostics, Inc . (OTC PINK:JMDP), a molecular diagnostics-based organization focused on improving patient management strategies for people living with preneoplastic and cancerous esophageal diseases, today announced that the Company's ...
NEW YORK, NY / ACCESSWIRE / October 22, 2020 / Stella Diagnostics, Inc . (OTC PINK:JMDP), a molecular diagnostics-based organization focused on improving patient management strategies for over 67 million people living with severe esophageal disease, today announced that Chief Executive Offi...
Stella Diagnostics, Inc . (OTC Markets: JMDP – name change to STLA pending), a molecular diagnostics-based organization focused on improving patient management strategies for over 67 million people living with severe esophageal disease, today announced that Chief Executive Of...
Stella Diagnostics, Inc . (OTC Markets: JMDP), a molecular diagnostics-based organization focused on improving patient management strategies for over 67 million people living with severe esophageal disease, announced today that it was selected as the Buzz of BIO winner for the 2...
News, Short Squeeze, Breakout and More Instantly...
JMD Properties Inc Company Name:
JMDP Stock Symbol:
OTCMKTS Market:
SALT LAKE CITY, UT / ACCESSWIRE / March 23, 2021 / Stella Diagnostics, Inc . (OTC Markets:JMDP) ("Stella" or "The Company") announced today that the Company's Chief Executive Officer, Dr. Joe Abdo, will participate in the Benzinga Biotech Small Cap Conference to be held virtually March 24-2...
KANSAS CITY, KS / ACCESSWIRE / March 16, 2021 / Stella Diagnostics, Inc . (OTC PINK:JMDP) ("Stella" or "The Company") has announced a Collaborative Research Agreement with the University of Kansas Medical Center ("KU Medical Center") to assess the predictability and clinical utility of th...
SALT LAKE CITY, UT / ACCESSWIRE / February 25, 2021 / Stella Diagnostics, Inc . (OTC PINK:JMDP) ("Stella" or "The Company") today announced that it has appointed Peter A. Cohen, Seth Platt, and David Seaburg to its Board of Directors. The three new members have decades of experience in asse...